Rome, June 16, 2023 – Cube Labs S.p.A. ("Cube Labs" or "Company") - an Italian venture builder in the healthcare technlogy sector and listed on the Euronext Growth Milan market,…
27 February 2023ROME, Italy Cartilago SRL (”Cartilago”), a clinical stage regenerative medicine company founded by Cube Labs, announced today that the United States Patent & Trademark Office (”USPTO”) has issued…
Rome, Italy 11th November, 2022 – Cartilago, a clinical stage regenerative medicine company founded by Cube Labs, announced today the results from an analysis of 21 subjects with a mean…
ROME, Italy Cartilago, a clinical stage regenerative medicine company, has announced a clinical study for Regen Longevity, a regenerative peptide candidate being developed to increase overall skin health and for…
Cartilago has received seed investment from CDP Venture Capital - National Innovation Fund of Italy’s "Italy Venture II - Southern Italy Business Fund." The fund aims to support outstanding startups…